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Transcranial magnetic stimulation to assess motor neurophysiology
after acute stroke in the United States: Feasibility, lessons learned, and
values for future research
Transcranial magnetic stimulation (TMS) has been widely
applied in both basic and clinical neuroscience since its introduction in 1985. In addition to its potential therapeutic value for
exciting or inhibiting neural circuits [1], TMS can be used to investigate corticomotor excitability (CME), which is a key aspect of
voluntary movement [2]. For example, single-pulse TMS can elicit
electrical signals, which propagate along descending motor pathways and are recorded as motor evoked potentials (MEP) in target
muscles. After stroke, TMS-evoked MEPs have been used to assess
the integrity of the descending corticospinal tract (CST) and prognosticate upper limb function [3,4]. Assessment of MEP presence
(MEPþ) or absence (MEP-) in the affected hand muscle (i.e., ﬁrst
dorsal interosseus (FDI)) at 5e7 days post-stroke is proposed to estimate long-term upper limb function with an MEPþ response predictive of better motor outcomes [5,6]. However, assessment of
acute stroke MEP status has yet to be implemented in the United
States (US). Performing TMS testing during a poststroke acute hospital stay is challenging, particularly in the US healthcare system
where hospital stays are 3.9e6.7 days on average [7] and literature
provides little guidance on implementation. Further, the dichotomous categorization of MEPþ/MEP- may estimate the CST integrity
in an over-simpliﬁed way [4,8]. It is possible that other neurophysiologic measures assessed by TMS may be complementary biomarkers to characterize pathophysiology and assist estimates of
motor function, but the feasibility of collecting these data in an
acute hospital setting has not been well described.
Our primary aim was to develop a feasible process for collecting
TMS-evoked responses at bedside, acutely post-stroke in a US hospital. The secondary aim was to assess the potential utility of additional
TMS-evoked
responses
to
better
characterize
neurophysiology in acute stroke. We discuss the necessary coordination, setup, and the lessons learned to facilitate the use of this
potentially important tool. TMS measures collected include bilateral resting motor threshold (RMT, measuring CME) [1], cortical silent period (cSP, measuring intracortical inhibition) [9], and
ipsilateral silent period (iSP, measuring interhemispheric inhibition) [10]. These measures reﬂect excitatory and inhibitory processing of the primary motor cortices (M1) with a single-pulse TMS.
Implementing bedside TMS assessment requires close interdisciplinary coordination. An onsite coordinator approaches poststroke individuals within the ﬁrst few days after admission to
screen for contraindications, obtain informed consent, and communicate with TMS investigators who subsequently make every effort
to complete the TMS assessment prior to patient discharge.

Between August 2019 and June 2021, 61 people enrolled in a prospective cohort study e The Stroke Motor reHabilitation and Recovery sTudy (SMaHRT; NCT03485040) e at the Massachusetts
General Hospital were screened for eligibility. Forty-six people consented and 30 people completed the TMS assessments. Sixteen individuals were not able to receive TMS due to medical
complications or acute illness (N ¼ 7), discharge before testing
could occur (N ¼ 7), withdrawal due to surgery (N ¼ 1), or testing
impacted by COVID-19 restrictions (N ¼ 1). The participants were
4.9 ± 1.7 days (range: 2e8 days) post ﬁrst-onset ischemic stroke.
The methodology for TMS assessment was as follows. A transportable cart equipped with a single-pulse TMS unit, a 70-mm
ﬁgure-of-eight remote coil (The Magstim Company Ltd, UK), and
a neuronavigation system (BrainSight, Rogue Research Inc., Canada)
was used to wheel into a ward for bedside assessment (Fig. 1). The
participants were positioned upright either in a bedside chair or
long-sitting in bed. The investigators cleaned the skin to place a
subject tracker (for neuronavigation) on the forehead and surface
electrodes on bilateral FDI muscles to record electromyography
(EMG). A participant's head was co-registered into a T1 template
scan with neuronavigation to guide the search of hotspot in the
M1. The assessment procedures of each hemisphere (ipsilesional
hemisphere ﬁrst) are described below.
1 FDI Hotspot Localization and MEPþ/MEP- Determination. MEPþ
was deﬁned as any visible and consistent EMG response above
the background activity (typically >20mV) and occurring 25e40
milliseconds post-stimulus at an intensity up to 100% maximum
stimulator output (MSO). For those whose MEP could not be
elicited at rest, a voluntary contraction was performed to
generate background EMG activity to again attempt to obtain an
MEP.
2 RMT Determination (%MSO). The TMS Motor Threshold
Assessment Tool (MTAT 2.0) was used to determine RMT
deﬁned as 50mV [1]. MTAT was used due to the speed of
threshold determination with minimal number of pulses. If MEP
could only be elicited during active contraction, an active motor
threshold was not determined, but the individual was categorized as MEPþ.
3 cSP (contralateral to the stimulated hemisphere) and iSP (ipsilateral to the stimulated hemisphere) Measurements. Two silent
period
measures
were
obtained
simultaneously
(intensity ¼ 130% RMT) with bilateral FDI contraction [9,10]. If
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size ¼ 0.5). The ipsilesional/contralesional ratio of iSP was
0.9 ± 0.3, indicating a moderate effect of imbalanced interhemispheric inhibition (Supplementary Table 2).
A transportable TMS cart and efﬁcient interdisciplinary communication enable comprehensive, bedside TMS assessment to occur
in between complex medical patient needs during acute hospitalization in a US-based hospital. Corticomotor excitability and inhibition may help illuminate the dynamic and poorly understood
pathophysiology in acute stroke. The outlined process will enable
future research on identifying TMS-derived biomarkers for motor
function prognosis in stroke.
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Fig. 1. A transportable cart equipped with a TMS unit, a 70-mm ﬁgure-of-eight remote
coil, and a neuronavigation system. A reconstructed brain image with real-time
feedback of coil location was used to guide the stimulation in the primary motor
cortex. This cart can be wheeled into a ward and this setup allows TMS assessments to
occur acutely at the bedside.

cSP or iSP were not visible, stimulus intensity was increased
until cSP or iSP was observed, up to 100% MSO.
Demographics and TMS data are presented in Supplementary
Table 1. Testing required approximately 30e40 minutes to complete all measures in both hemispheres. There were seven individuals deﬁned as MEP-. Among the 23 MEPþ individuals, eight had no
RMT given the standard 50mV criteria (i.e., MEP<50mV at 100%
MSO). Medians of the RMT were 48% (ipsilesional) and 44% (contralesional) (95% conﬁdence interval (CI) of difference: 5.1, 4.9; effect size ¼ 0.007). Since the silent period requires muscle
contraction, data were unavailable in some individuals with severe
hemiparesis due to inability to perform active contraction. Medians
of the cSP were 245.7 ms (ipsilesional) and 169.8 ms (contralesional) (95% CI of hemisphere difference: 30.7, 121.0; effect
size ¼ 1.2). The ipsilesional/contralesional ratio of cSP was
1.5 ± 0.5, indicating a strong effect of greater ipsilesional intracortical inhibition. Medians of the iSP were 40.7% (ipsilesional) and
52.3% (contralesional) (95% CI of difference: 17.2, 0.3; effect
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